메뉴 건너뛰기




Volumn 39, Issue 3, 2012, Pages 459-469

Production of polyhydroxyalkanoates by Burkholderia cepacia ATCC 17759 using a detoxified sugar maple hemicellulosic hydrolysate

Author keywords

Burkholderia cepacia; Detoxification; Fermentation; Hemicellulosic hydrolysate; Polyhydroxyalkanoates

Indexed keywords

ACETIC ACID; CARBOHYDRATE DERIVATIVE; DETOXIFED SUGAR MAPLE HEMICELLULOSIC HYDROLYSATE; FURFURAL; LEVULINIC ACID; POLYHYDROXYALKANOIC ACID; UNCLASSIFIED DRUG; VANILLIN;

EID: 84863309477     PISSN: 13675435     EISSN: 14765535     Source Type: Journal    
DOI: 10.1007/s10295-011-1040-6     Document Type: Article
Times cited : (160)

References (17)
  • 3
    • 34347374452 scopus 로고    scopus 로고
    • Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli
    • de Marco A, Deuerling E, Mogk A et al (2007) Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli. BMC Biotechnol 7:32
    • (2007) BMC Biotechnol , vol.7 , pp. 32
    • De Marco, A.1    Deuerling, E.2    Mogk, A.3
  • 4
    • 0035545747 scopus 로고    scopus 로고
    • Whole cell ELISA for detection of tumor antigen expression in tumor samples
    • DOI 10.1016/S0022-1759(01)00465-3, PII S0022175901004653
    • Erdile LF, Smith D, Berd D (2001) Whole cell ELISA for detection of tumor antigen expression in tumor samples. J Immunol Methods 258:47-53 (Pubitemid 33016525)
    • (2001) Journal of Immunological Methods , vol.258 , Issue.1-2 , pp. 47-53
    • Erdile, L.F.1    Smith, D.2    Berd, D.3
  • 5
    • 33847422253 scopus 로고    scopus 로고
    • T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunity
    • DOI 10.2174/156800907780006841
    • Foell J, Hewes B, Mittler RS (2007) T cell costimulatory and inhibitory receptors as therapeutic targets for inducing anti-tumor immunity. Curr Cancer Drug Targets 7:55-70 (Pubitemid 46345508)
    • (2007) Current Cancer Drug Targets , vol.7 , Issue.1 , pp. 55-70
    • Foell, J.1    Hewes, B.2    Mittler, R.S.3
  • 6
    • 74149084929 scopus 로고    scopus 로고
    • Adjuvantive eVects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: DiVerent eVects on cellular and humoral immunity
    • Ganguly S, Liu J, Pillai VB et al (2010) Adjuvantive eVects of anti-4-1BB agonist Ab and 4-1BBL DNA for a HIV-1 Gag DNA vaccine: diVerent eVects on cellular and humoral immunity. Vaccine 28:1300-1309
    • (2010) Vaccine , vol.28 , pp. 1300-1309
    • Ganguly, S.1    Liu, J.2    Pillai, V.B.3
  • 7
    • 47349101176 scopus 로고    scopus 로고
    • Extracellular domain of 4-1BBL enhanced the antitumoral eYcacy of peripheral blood lymphocytes mediated by anti-CD3 σ anti-Pgp bispeciWc diabody against human multidrug-resistant leukemia
    • Guo H, Jiang W, Liu W et al (2008) Extracellular domain of 4-1BBL enhanced the antitumoral eYcacy of peripheral blood lymphocytes mediated by anti-CD3 σ anti-Pgp bispeciWc diabody against human multidrug-resistant leukemia. Cell Immunol 251:102-110
    • (2008) Cell Immunol , vol.251 , pp. 102-110
    • Guo, H.1    Jiang, W.2    Liu, W.3
  • 8
    • 77956214554 scopus 로고    scopus 로고
    • Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice
    • Lin GH, Liu Y, Ambagala T et al (2010) Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice. PLoS One 5:e11003
    • (2010) PLoS One , vol.5
    • Lin, G.H.1    Liu, Y.2    Ambagala, T.3
  • 9
    • 41149173311 scopus 로고    scopus 로고
    • The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer
    • DOI 10.1111/j.1600-065X.2008.00621.x
    • Lynch DH (2008) The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer. Immunol Rev 222:277-286 (Pubitemid 351430383)
    • (2008) Immunological Reviews , vol.222 , Issue.1 , pp. 277-286
    • Lynch, D.H.1
  • 10
    • 85027954154 scopus 로고    scopus 로고
    • A functional recombinant human 4-1BB ligand for immune costimulatory therapy of cancer
    • Meseck M, Huang T, Ma G et al (2011) A functional recombinant human 4-1BB ligand for immune costimulatory therapy of cancer. J Immunother 34:175-182
    • (2011) J Immunother , vol.34 , pp. 175-182
    • Meseck, M.1    Huang, T.2    Ma, G.3
  • 11
    • 0031860811 scopus 로고    scopus 로고
    • Chaperone coexpression plasmids: Differential and synergistic roles of DnaK-DnaJ-GrpE and GroEL-GroES in assisting folding of an allergen of Japanese cedar pollen, Cryj2, in Escherichia coli
    • Nishihara K, Kanemori M, Kitagawa M et al (1998) Chaperone coexpression plasmids: diVerential and synergistic roles of DnaKDnaJ-GrpE and GroEL-GroES in assisting folding of an allergen of Japanese cedar pollen, Cryj2, in Escherichia coli. Appl Environ Microbiol 64:1694-1699 (Pubitemid 28234771)
    • (1998) Applied and Environmental Microbiology , vol.64 , Issue.5 , pp. 1694-1699
    • Nishihara, K.1    Kanemori, M.2    Kitagawa, M.3    Yanagi, H.4    Yura, T.5
  • 12
    • 66849135251 scopus 로고    scopus 로고
    • Cancer immunotherapy: Co-stimulatory agonists and co-inhibitory antagonists
    • Peggs KS, Quezada SA, Allison JP (2009) Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists. Clin Exp Immunol 157:9-19
    • (2009) Clin Exp Immunol , vol.157 , pp. 9-19
    • Peggs, K.S.1    Quezada, S.A.2    Allison, J.P.3
  • 13
    • 29244444176 scopus 로고    scopus 로고
    • Production of recombinant human trimeric CD137L (4-1BBL): Cross-linking is essential to its T cell co-stimulation activity
    • DOI 10.1074/jbc.M506881200
    • Rabu C, Quemener A, Jacques Y et al (2005) Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity. J Biol Chem 280: 41472-41481 (Pubitemid 41832207)
    • (2005) Journal of Biological Chemistry , vol.280 , Issue.50 , pp. 41472-41481
    • Rabu, C.1    Quemener, A.2    Jacques, Y.3    Echasserieau, K.4    Vusio, P.5    Lang, F.6
  • 14
    • 70649103798 scopus 로고    scopus 로고
    • A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity
    • Schabowsky RH, Elpek KG, Madireddi S et al (2009) A novel form of 4-1BBL has better immunomodulatory activity than an agonistic anti-4-1BB Ab without Ab-associated severe toxicity. Vaccine 28:512-522
    • (2009) Vaccine , vol.28 , pp. 512-522
    • Schabowsky, R.H.1    Elpek, K.G.2    Madireddi, S.3
  • 15
    • 0028899550 scopus 로고
    • ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages
    • Schwarz H, Valbracht J, Tuckwell J et al (1995) ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood 85:1043-1052
    • (1995) Blood , vol.85 , pp. 1043-1052
    • Schwarz, H.1    Valbracht, J.2    Tuckwell, J.3
  • 16
    • 77952845427 scopus 로고    scopus 로고
    • 4-1BB ligand as an eVective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines
    • Sharma RK, Schabowsky RH, Srivastava AK et al (2010) 4-1BB ligand as an eVective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines. Cancer Res 70:3945-3954
    • (2010) Cancer Res , vol.70 , pp. 3945-3954
    • Sharma, R.K.1    Schabowsky, R.H.2    Srivastava, A.K.3
  • 17
    • 77950568379 scopus 로고    scopus 로고
    • The structure of the trimer of human 4-1BB ligand is unique among members of the tumor necrosis factor superfamily
    • Won EY, Cha K, Byun JS et al (2010) The structure of the trimer of human 4-1BB ligand is unique among members of the tumor necrosis factor superfamily. J Biol Chem 285:9202-9210
    • (2010) J Biol Chem , vol.285 , pp. 9202-9210
    • Won, E.Y.1    Cha, K.2    Byun, J.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.